Infectious disease Flashcards

(79 cards)

1
Q

Threadworm

A

Background:
AKA pin worm or enterobiasis
Most common parasitic infection in the UK, very widespread.
Normally affects children

Aetiology:
Nematode infection - enterobius vermicularis, typically white in colour and roughly 1cm in length

Risk factors:
Prevalence highest in ages 5-9 YO

Presentation:
Pruritus of the anus or vulva (tend to lay eggs around the vulva)
Typically worse at night (when worms lay their eggs)
Vaginal discharge
Urinary tract infections
Bed wetting that is not usual for them
May see worms around the anus or vulva region at night/during bathing
Asymptomatic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Threadworm Ix, Mx and prevention

A

Investigation/diagnosis:
Safeguarding if abuse is suspected
Clinical diagnosis if diagnosis is obvious
If uncertain - adhesive tape test to look for eggs can be done (place tape around perianal skin to look for eggs under microscope)
Stool examination is not recommended as is only positive in 5% of cases

Management:
General hygiene advice, shower everyday, regular bed linen and towel changes, regular hand washing
Advice for all family members to be treated if one member has an infection
Mebendazole 100 mg (can buy OTC) in those ages 6 months + (specialist advice for those under age 6 months)
Typically a single dose, should be repeated 2 weeks after initial dose to ensure infection is gone as it does not kill eggs.
2nd line - albendazole or pyrantel pamoate

Prevention:
General hygiene advice, shower everyday, regular bed linen and towel changes, regular hand washing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Hookworm

A

Background:
Typically infected in more tropical locations as they like to live in more humid climates.
Second most common helminthic infection in the world, affecting one in four of the world’s population
Not that common in the UK

Pathology:
Typically live in the small intestines of hosts
Infection spread by walking on, handling or laying on infected ground or soil
Eggs are passed through the stool, typically hatch within 1-2 days after being passed.
On contact with human host they penetrate the skin and are carried through the bloodstream to the heart and lungs
Penetrate alveoli and bronchial tree to the pharynx where they are swallowed
Work into the small intestines where they mature into adults, attach to the intestinal wall and lay eggs
Irritation occurs mostly due to GIT inflammation

Aetiology:
Parasitic nematodes.
Two types known to infect humans - ancylostoma duodenale and necator americanus

Risk factors:
Warmer climates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Hookworm presentation and investigation

A
Presentation:
Asymptomatic mostly 
Nausea
Abdominal pain
Diarrhoea 
Iron deficiency anaemia 
Local skin irritation and pruritus 
Respiratory symptoms (dyspnoea)
Anaemia and malnutrition can cause developmental delay in children/poor growth 

Investigation/diagnosis:
Bloods - FBC (eosinophilia)
Stool microscopy for worms and eggs (diagnostic usually)
CXR - alveolar infiltration in migration stage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Hookworm management and prevention

A

Management:
Albendazole - most effective, may need multiple doses
Mebendazole 2nd line
Iron and vitamin supplementation B12, folate
If in cutaneous phase - local cryotherapy
More severe cases - surgical endoscopic removal to reduce the amount of parasites
Rapid reinfection is common in endemic areas

Prevention:
Do not walk barefoot on soil/outdoors
Don’t defecate outdoors
Don’t use human faeces or raw sewage as fertiliser
Community control is difficult in less developed countries due to lack of sanitation and resources

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Malaria

A

Background:
Mortality is 0.2% and each year 500 million are affected
In endemic areas mortality is mainly in infants and those who survive to adulthood acquire significant immunodeficiency
Transmitted by bite of infected female anopheline mosquitoes; can also be vertically transmitted mother to baby

Types:
Plasmodium falciparum - most fatal; symptoms of mild infection which rapidly progress to fever with rigors, severe multiorgan failure, coma and death
Non-falciparum malaria - P. vivax, P. ovale, P.malariae which cause more benign illness but may relapse after treatments

Aetiology:
Protozoan parasite

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Malaria pathology

A

Pathology:
Insect bite; sporozoites pass through skin and via bloodstream to the liver
Multiple inside hepatocytes as merozoites
After a few days the infected hepatocytes rupture releasing merozoites into the blood
Enter erythrocytes and cause subsequent rupture
Causes anaemia and release pyrogens causing rigors and fever
The sequence of entering and rupturing RBCs occurs harmoniously every day causing rigor, fever then severe sweating in constant cycle throughout infection
Infected RBCs with P. falciform adhere to the endothelium of small vessels causing vascular occlusion, severe organ damage to multiple organs
RBCs destroyed more causing jaundice, also invades the liver causing malfunction (jaundice)
P. ovale and P. vivax remain latent in the liver and this is responsible for relapses that may occur after treatment
Tests will show gametocytes of the mosquito in the blood
When more than 1% RBCs are infected it may cause cerebral malaria or blackwater fever

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Malaria presentation and complications

A

Presentation:
Incubation period 10-14 days in P. vivax, P. ovale and P. falciform infection
18 days to 6 weeks incubation in P. malariae infection
Abrupt onset of rigors, fever (>40 degrees)
Tachycardia
Followed by profuse sweating for some hours later
May show anaemia and hepatosplenomegaly and jaundice
Nausea and vomiting, dry cough, headache, fatigue, pain
Hypoglycaemia is severe complication of malaria presents similarly to cerebral malaria so must be ruled out
Cerebral malaria: altered consciousness, confusion, convulsions, coma and eventually death.
Blackwater fever: severe haemolysis, haemoglobinuria (dark brown/black urine)

Complications - anaemia, liver failure, kidney failure, ARDS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

malaria investigation and prevention

A

Investigation:
Blood testing: FBC (anaemia), blood smear (thick and thin with Giemsa stain GOLD STANDARD FOR DIAGNOSIS), creatinine and urine output, clotting screen, LFTs, U+Es, glucose, BM, ABG/lactate, urinalysis
Microscopy of thick (diagnosis of malaria) and thin (percentage of infected RBCS and species identification) blood smear
CXR
Rapid diagnostic test detects parasite antigen

Prevention:
Aware of risks
Bite avoidance: repellants, permethrin impregnated clothing, sleeping under impregnated bednets
Chemoprophylaxis: mefloquine, doxycycline, chloroquine, malarone: start drug at least 1 week before departure and continue for 4 weeks without interruption after return

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Malaria management

A

Management:
Notifiable disease (public health)
P. falciform infection is a medical emergency due to fast degeneration of patient
Always immediate referral to specialists for management

Uncomplicated: symptomatic but no severe signs, vital organ dysfunction and parasitic count <2%
Non-falciparum gives chloroquine (0, 6, 24, 48 hours) + Primaquine for 2 weeks (to eradicate P. vivax and P. ovale from liver)

Uncomplicated P. falciparum gives ACT + Primaquine single dose
Falciparum malaria - quinine sulphate + doxycycline for 7 days

Severe falciparum malaria: presence of impaired conscious/seizures, AKI, shock, hypoglycaemia, pulmonary oedema, Hb <80g/L, spontaneous bleeding, acidosis, haemoglobinuria, parasitaemia >10%
Artesunate IV first line
Quinine IV with DW5% second line

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Toxoplasmosis

A

Background:
Widespread global infection

Pathology:
Main host is cats, eggs are excreted in cat faeces then mature in the environment
Potentially ingested by secondary hosts
Can transmit to pregnant mothers, especially during the 1st trimester, incidence increases from 14% to 59%
Primary infection is usually subclinical but can lead to chorioretinitis or may damage foetal in pregnancy
Reactivation of latent infection in immunocompromised patients may cause life-threatening encephalitis

Aetiology:
Toxoplasma gondii, an intracellular protozoan parasite

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

toxoplasmosis presentation, Ix and Mx and prevention

A

Presentation:
Mostly asymptomatic in healthy non-pregnant individuals
Ocular toxoplasmosis - visual symptoms, floaters, uveitis, reduced auticity
Immunocompromised - encephalitis, pneumonitis, multiorgan failure and shock
Congenital infections
Neonates - convulsions, microcephaly, hepatosplenomegaly, jaundice, hydrocephalus, mental retardation, defective vision

Investigation/diagnosis:
Serological screening in pregnancy (IgG and IgM)
MRI or CT for brain lesions
Foetal USS if suspected maternal infection

Management:
Healthy non-pregnant people - no treatment unless symptoms are severe, persistent or incurred through blood products or lab transmission
Treated with pyrimethamine, sulfadiazine and folinic acid for 4-6 weeks
If positive during pregnancy - given spiramycin ASAP then treatment as above until term or until foetal infection documented
Immunocompromised - trimethoprim/sulfamethoxazole is effective

Prevention:
Avoid cleaning cat litter
Good hygiene around cats/cat faeces

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Amoebiasis

A

Background:
Infection of the GIT with entamoeba species
Infects approx. 50 million people worldwide, of which 100,000 die annually

Pathology:
Transmitted by contaminated water, ingestion of mature cysts in food/water or contamination with faeces.
Cysts enter small intestines and release active amoebic parasites which invade the epithelial cells of the large intestines, causing flask shaped ulcers. Infection can then spread from intestines to other organs (lungs, liver, brain etc.) via the venous system.
Causes amoebic dysentery
Asymptomatic carriers pass cysts in faeces and carriage state can persist indefinitely
Cysts remain viable for up to 2 months
Incubation may be between 7 days - 4 months

Aetiology:
Protozoan entamoeba histolytica

Risk factors:
Common in south and central america, west africa and southeast asia
Travellers and immigrants
Residents of institutions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Amoebiasis presentation, Ix and Mx

A

Presentation:
Often asymptomatic
Abdominal pain and diarrhoea, later developing dysentery
Rectal bleeding
Abdominal mass (usually in RIF)
Hepatic amoebiasis - sweating, pyrexia, painful liver/diaphragm, weight loss, fever, hepatomegaly

Investigation/diagnosis:
Stool sample
Bloods - FBC (leukocytosis), ESR, LFTs, parasite serology
PCR test
USS, CT, MRI
Proctoscopy, sigmoidoscopy, colonoscopy for mucosal scrapings and biopsy

Management:
Metronidazole antibiotic for acute invasive amoebic dysentery
Diloxanide furoate for asymptomatic patients (10 day course)
Fluid and electrolyte replacement
Gastric suction
Blood transfusion PRN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Candidiasis

A

Background:
Infection ranges from local to disseminated
Most severe/common in immunocompromised patients
Most common fungal infection within hospitals
Pathology:

Types:
Oral
Oesophageal 
Vulvovaginal 
Skin
Invasive 

Aetiology:
Combination or various different candida infections, most commonly candida albicans
Best like fungi which can be part of the normal flora of the human body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Candidiasis risk factors

A
Immunocompromised patients (including diabetics)
Antibiotics use
Poor oral hygiene 
Intensive care patients
Pregnancy 
Radiotherapy 
Steroid inhalers (oral thrush)
Oral steroids
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

oral thrush overview

A

Very common
Typically presents with sore mouth, coated tongue, bad breath
Coating is easily removed showing red mucosa
Can bleed easily on contact
Take swabs to confirm species but is clinical diagnosis
If recurrent may swab, history (oral or inhaled steroid use) or take bloods, urinalysis to investigate cause (diabetes, HIV)
Mx with topical agents: daktarin gel or nystatin solution (antifungal mouthwashes) used for a week or longer
If not responding swab for resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

oesophageal candidiasis overview

A

Normally progresses from oral thrush
Oral symptoms along with dysphagia, retrosternal pain and odynophagia
Normally associated with treatment of malignancy (chemo or radiotherapy)
If HIV positive then need urgent admission to hospital as is an AIDS defining illness
Refer to secondary care as it can become a severe infection
Treated with oral fluconazole 200-400 mg BD for 2-3 weeks
Urgent admission to hospital for any signs of systemic illness.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

vulvovaginal thrush overview

A

Very common
Often caused by fluctuation of oestrogen, vaginal flora and pH
70% of women will likely have thrush at some point
One of the most common causes of vaginitis
Symptoms include pruritus, vulval soreness, discharge, dyspareunia, dysuria.
Take swabs of discharge to rule out STIs
Emollients for itching or excoriated, avoid irritants like perfumed soaps or bubble baths
Intravaginal or topical clotrimazole and oral fluconazole one off treatment
If symptoms persist after 7-14 days then follow up is needed to investigate underlying causes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Skin infections (candidiasis) overview

A

Typically on the hands, feet or moist skin folds
Areas are sore, itchy, erythematous
Skin can slough off or can be white like discharge
Intertrigo is a common form
Typically only investigate for recurrent or non-responsive treatment
Topical antifungals normally treat this well
Miconazole cream topically 2-3 x daily for a week
Daktacort (hydrocortisone + miconazole) helps with itching and infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Invasive candidate infection overview

A

Variety of severe disease caused by candida infection, most commonly candidemia
Normally has underlying immunocompromise or critical illness, abdominal surgery, implants or catheters
Low index of suspicion for those with spiking fever, neutropenic and have risk factors
Take blood cultures, swab any catheter lines, culture of bodily fluids, serology testing for fungal disease beta D glucan
Mx IV antifungal agents (caspofungin, fluconazole, voriconazole)
Always discuss with infectious disease specialist for best management

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Crytococcus

A

Background:
Invasive budding yeast fungus
Major cause of mortality in HIV +ve patients worldwide despite antiviral therapy

Pathology:
Abundant in soil contaminated with pigeon droppings
Once infected, can affect several organs but mostly causes meningitis or meningoencephalitis

Aetiology:
Cryptococcus yeast species
Two serotypes - type A (majority of cases) and type D

Risk factors:
Immunocompromised patients are most at risk (HIV +ve, diabetes, hepatic cirrhosis, steroids, sarcoidosis, connective tissue disorders)
Solid organ transplant recipients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Cryptococcus presentation, investigation, management and prevention

A
Presentation:
Cough
Pleuritic chest pain 
SOB
Headache
N+V
Confusion and behavioural changes
Brain abscess
Meningitis (neck stiffness, photophobia)
Investigation/diagnosis:
Bloods - cultures, FBC, LFTs
Urinalysis and cultures
LP - CSF analysis for fungal meningitis 
CXR
MRI

Management:
Fluconazole if mild for minimum of 8 weeks
Amphotericin B if severe
Maintenance therapy low dose of oral fluconazole for 6-12 months

Prevention:
Prophylaxis with fluconazole in HIV+ve patients with CD4 count <100cell/mm3 (not always effective)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Histoplasmosis

A

Background:
Systemic fungus found in soil, widespread
Common in the USA

Pathology:
Found in bat/bird droppings and soils.
Transmitted via inhalation and usually occurs as an atypical pneumonia
Affects organs and can cause organ failure in severe cases

Aetiology:
Histoplasmosis fungal infection

Risk factors:
Immunocompromised patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Histoplasmosis presentation, Ix, Mx and prevention
``` Presentation: Fever, chills, headache Dry cough Muscle aches Chest discomfort Joint pain Rash Immunocompromised patients - disseminated infection, fever, dyspnoea, cough, loss of weight, prostration with hepatosplenomegaly, usually fatal within 6 weeks. ``` Investigation/diagnosis: Clinical history and presentation Swab cultures Management: Antifungal - itraconazole for mild-moderate cases Amphotericin in severe cases if itraconazole fails Prevention: Face masks in high risk environment e.g. poultry workers Prevent exposure
26
Pneumocystis infection
Background: Atypical fungi that causes pneumonia in humans and occasionally extrapulmonary disease Widespread globally Major cause of morbidity and mortality among immunocompromised people Leading AIDS-defining opportunistic infection in HIV +ve people Pathology: Causes fungal pneumonia Aetiology: Pneumocystis jirovecii Risk factors: Immunocompromised patients are most at risk (HIV +ve, steroids, chemotherapy, organ transplant patients, severe malnutrition etc.)
27
Pneumocystis presentation, Ix, Mx and prevention
``` Presentation: Cough - usually non-productive Exertional dyspnoea Fever Tachypnoea Chest pain Underlying conditions (AIDS, immunocompromised) Scattered crackles and/or wheezes may be present Hepatosplenomegaly Lymphadenopathy Ocular disease ``` ``` Investigation/diagnosis: Bloods - LDH elevated, ABG PCR test CXR/CT Sputum sample Lung biopsy Spirometry ``` Management: High dose co-trimoxazole Prevention: High dose co-trimoxazole
28
Gram staining morphology
Differential stain based on cell wall structure (cellular morphology) Cocci - round Rods - bacilli Clusters - cocci in clusters Most food poisoning bacteria are gram negative bacillus
29
Lyme disease
Background: Quite rare but incidences are rising In the UK is most common in Exmore, new forest, south downs etc. where deer are present Peak age of incidence are 24-44 and 45-65 YO Pathology: Disease is caused by infection and body immune response to the infection Different strains cause different clinical manifestations Transmitted from host to host by ixodes ticks or deer ticks Ixodes ticks emerge from larval form in summer and feeds on one animal host, then becomes nymph and feeds only once again on another host (humans can be victims in this stage) In autumn the adult tick emerges to feed on deer again once. Humans can also be host at this stage. The tick must be significantly infected to pass on spirochaete infection Often the host clears the infection and remains asymptomatic but seropositive OR elicits immune response causing clinical presentation Aetiology: Caused by spirochaete bacterium borrelia burgdorferi
30
Lyme disease risk factors and presentation
Risk factors: Areas with high prevalence Presentation: Early/stage 1/localised disease: circular rash at site of infestation within 3-36 days. Rash is round/oval, pink/red or purple. Often central erythema with sparing around it gives a target-like appearance. Eventually resolves after some weeks later/stage 2 disease/disseminated: flu like symptoms; malaise, muscle and joint pains, fever, tiredness, nausea or vomiting Neurological disorders can occur in 10% untreated cases: uni/bilateral facial nerve palsies, meningism, meningitis, mild encephalitis, peripheral mononeuritis Cardiovascular problems Lymphocytomas - bluish red nodular lesions typically on earlobe or nipple Late/stage 3 disease: arthritis, acrodermatitis chronica, late neurological disorders (polyneuropathy, chronic encephalomyelitis, vertigo and psychosis), chronic lyme disease Acrodermatitis chronica atrophicans - blue discolouration on top of feet and hands
31
Lyme disease investigation and management
Investigation: Clinical diagnosis of classical target rash or with erythema migrans and tick bite history Bloods - antibody testing for B. Burgdorferi PCR testing for new onset arthritis and symptoms of lyme disease Management: Remove tick with fine tipped tweezers pull upwards without twisting Clean site after with antiseptic Rash: Treat oral antibiotics for 2-3 weeks doxycycline or amoxicillin Erythema migrans - doxycycline 100 mg BD for 3 weeks or amoxicillin 500 mg TDS for 3 weeks if allergic to doxycycline Seek advice from infectious diseases for any other symptoms with likely history of tick bite Flu-like symptoms, facial palsy or neurological symptoms after tick bite - speak with infectious disease specialists and consider serology testing. If there is a high suspicion of Lyme disease, treat while awaiting results.
32
Salmonellosis
Background: Salmonella gastroenteritis One of the most common forms of food poisoning worldwide Pathology: Found in foods such as chicken and other poultry Typically invade intestinal mucosa and produce toxins causing GIT symptoms from inflammation Incubation between 6-72 hours Aetiology: Salmonella Spp. bacteria toxins Risk factors: Contaminated foods Undercooked foods International travel to regions with poor hygiene and sanitation or lack of farm vaccination
33
Salmonellosis presentation, Ix, Mx and prevention
``` Presentation: Most symptoms are mild and self-limiting Diarrhoea (can be bloody) Fever Abdominal cramping N+V Symptoms tend to last 4-7 days ``` Investigation/diagnosis: >7 days diarrhoea - send off stool microscopy Dehydration status Bloods for ongoing symptoms - U+Es (electrolyte disturbance) Management: Good fluid intake, eating little and often stick to bland foods Rest, avoid public areas like schools/work until 48 hours after last bout of diarrhoea/vomiting Loperamide (CI for IBD, dysentery, shigella, E. coli, pseudomembranous colitis) Antibiotics only in >50 YOs, immunocompromised or under 6 months old Prevention: UK vaccinate livestock such as hens
34
Shigellosis
Background: Highly contagious Human and apes seem to be only natural hosts Rare in the UK Pathology: Spread by contaminated water, swimming pools and foods Causes bacterial dysentery due to bacteria causing damage and inflammation to the colon Incubation period of 1-3 days Aetiology: Gram negative bacilli shigella Risk factors: Recent travel abroad
35
Shigellosis presentation, Ix, Mx and prevention
``` Presentation: Normally very watery diarrhoea, can be bloody, mucus and pus Abdominal pain Tenesmus Fever and malaise Self limiting normally ``` Investigation/diagnosis: Stool sample for culture >7 days diarrhoea Dehydration check Bloods for ongoing symptoms - U+Es for electrolyte disturbances Management: Oral rehydration Paracetamol for pain and fevers Consider antibiotics for positive stool sample (only reduce symptoms by 1-2 days) often not given/needed as self-limited Do NOT give antimotility agents due to complications such as toxic megacolon Avoid public space (school, work) until 48 hours after V+D has ceased to prevent infection Inform local public health team as notifiable disease Prevention: Good hygiene
36
E. coli bacteria
Normal intestinal bacteria Spread via contact with infected faeces, unwashed salads or contaminated water E.coli 0.157 produces shiga toxin causing cramps, bloody diarrhoea and vomiting and can lead to haemolytic uraemic syndrome therefore should AVOID antibiotics if suspected infection
37
Campylobacter bacteria
Most common bacterial cause of gastroenteritis (travellers diarrhoea) Gram negative curved or spiral shaped bacteria Spread from improperly cooked poultry, untreated water or unpasteurized milk Usually resolves around 3-6 days, causes abdo cramps, diarrhoea (bloody), vomiting, fever Consider antibiotics after isolating bacteria if there are severe symptoms or other comorbidities - treat with azithromycin or ciprofloxacin
38
Staph aureus toxin
Can produce enterotoxins on foods such as eggs, diary, meat Causes diarrhoea, profuse vomiting, abdo cramps and fever Resolve within 12-24 hours
39
Cholera
``` Background: Acute diarrhoeal infection in the GIT Linked to epidemics and pandemics Not usually seen in the UK Most common in southeast asia, africa and south america 3-5 million people affected annually ``` Pathology: Water-borne infection caught by ingestion of faecally contaminated water or shellfish then leads to infection of the GIT Incubation is usually 2-5 days but can sometimes be a few hours and are infectious for 7-14 days. Produces an AB type enterotoxin (binds to host cells and viral component) enabling it to enter the cell and increase loss of chloride ions during viral replication process, causing an increase loss in salt and water in the GIT leading to extreme watery diarrhoea which can be fatal if dehydration is not corrected with clean water. Aetiology: Caused by the enterotoxin subunit-A of Vibrio cholerae bacterium (gram negative comma shaped bacteria) There are over 100 serotypes of V. cholerae but only two cause disease - O1 (has two variants called classical and EI Tor) and O139.
40
cholera risk factors and presentation
Risk factors: Poor sanitation in endemic areas Poor water supply/sanitation in endemic areas Poorly cooked seafoods in endemic areas Presentation: 75% asymptomatic High volume of watery diarrhoea (rice water stools) Severe dehydration and circulatory collapse (hypovolaemia) N+V Fluid loss can be up to 20L per day
41
Cholera investigation and management and prevention
Investigation/diagnosis: Stool culture and sensitivities Dehydration status (1kg of weight loss = 1L fluid loss roughly) Bloods - U+Es, FBC, WCC Management: Oral rehydration therapies IV fluids for severe dehydration Antibiotic treatment to decrease volume and duration of diarrhoea by 50% is recommended for patients with mod-severe dehydration (tetracycline, doxycycline or ciprofloxacin often used) but avoid if possible for resistance purposes Prevention: Improved sanitation Boil water before drinking, add chlorine tablets or drink bottled water The UK has licensed oral vaccines for those travelling to remote areas where access to medical treatment is limited or aid workers in disaster relief/refugee camps. It is effective against serotype O1 only for up to 2 years preventing 50-60% of cholera episodes. Primary immunisation for ages 6+ is two doses of oral vaccine (sachets) given 1-6 weeks apart with an advised booster to be taken within 6 months (ages 2-6) or 2 years (6+) since primary vaccination
42
Botulism
Background: Widespread environmental (soil) bacteria that can cause rare infection There are three naturally occurring forms as a result of biological warfare. It is regarded as the most lethal substance known, an estimated 1g could kill 1 million people. Three types: infant botulism (honey), food-borne (home canning) and wound botulism (contaminated wounds) Seven types of exotoxin exist, only A, B, E and F affect humans Exotoxins affect the neurological system Pathology: Found commonly in the soil, it is neutralised by water so cannot be dispersed in this. Only survives in anaerobic conditions, produces spores Food-borne - when spores germinate and bacteria reproduce in an environment outside of the body producing toxins, causes illness when food is ingested Wound botulism - organism enters an open wound and produces spores, it is the most common in IV drug use Infant botulism - rare aside from the USA where it is the most common type. Babies ingest spores which germinate in the gut and release toxins, only occurring in children due to not having natural defences against spores to prevent germination. Aetiology: Botulinum toxin of Clostridium botulinum (anaerobic gram positive bacillus)
43
Botulism risk factor and presentations
Risk factors: IV drug use ``` Presentation: Occurs within 2-8 days after toxin exposure Symmetric descending flaccid paralysis Ptosis, accommodation failure, pupil fixation (facial and oculomotor nerve paralysis) Dry mouth and throat Dysphagia N+V Abdominal distension Problems urinating Constipation Blurred vision Diplopia Slurred speech Tachycardia Respiratory paralysis Muscle weakness ```
44
botulism investigation, management and prevention
``` Investigation/diagnosis: Bloods - serum toxin Urinalysis Stool microscopy Vomit or gastric fluid samples Spirometry Pulse oximetry ABGs ``` Management: Monitor for respiratory failure Polyvalent antitoxin (A, B, E types) must be given promptly With supportive care of patient to monitor paralysis Mechanical ventilation if respiratory paralysis Prevention: Good food preparation and sanitation helps minimise cases There is no current vaccine licensed in the UK or effective against all serotypes
45
Tetanus
Background: Rare in the UK, largely a disease where there is inadequate vaccination Pathology: Found in soil, particularly soil rich manure as well as dust and faeces. Produces spores that enter a wound and cause muscle rigidity and spasms 3-21 days post infection One exotoxin is produced by spores. Infection spreads via lymph and blood, transported up nerves and binds irreversibly to neurons Prevents inhibition of motor reflex responses to sensory stimuli, resulting in muscle spasms which can be severe enough to tear muscles, cause long-bone fractures or spinal compression fractures and rigidity ``` Aetiology: Clostridium tetani (anaerobic gram positive bacillus). ```
46
tetanus risk factors and presentation
``` Risk factors: >60 YO Lack of immunisation Drug addiction Contaminated wounds (soil, rusty metals, manure) IM injections in surgery Poor obstetric techniques Neonatal tetanus - rural areas where deliveries are at home without sterile procedures ``` ``` Presentation: Exaggerated muscle reflexes and uncontrolled muscle spasms Lockjaw (trismus) Dysphagia Risus sardonicus (sneering appearance) Neck stiffness Opisthotonos (in neonates) Complications - aspiration pneumonia, laryngospasms and asphyxia, fractures, apnoea, HTN, cardiac arrest, PE ```
47
tetanus investigation and prevention
Investigation/diagnosis: Clinical diagnosis Spatula test - touch back of the pharynx with spatula to elicit bite reflex instead of gag reflex in tetanus infected individuals Prevention: Vaccine given as a standard tetanus, diphtheria and polio dose for adults and school leavers Primary course for those under age 10 also contains acellular pertussis and pre-school booster given. Doses given at 2, 3 and 4 months old then after age 10 given 3 more doses with an interval of at least 1 month in between doses. Give booster three years after completion of primary course (under 10) or five years after primary dose if over age 10. Second booster given to everyone after 10 years after first booster CI in allergies, neurological conditions, unwell with fever
48
tetanus management
Management: Human anti tetanus Ig given via IV in ICU Penicillin or metronidazole given to prevent bacterial growth (which produces more exotoxin) Clean the wound Consider prophylactic sedation and intubation, benzodiazepines to prevent/control spasms Botulinum toxin may reduce symptoms Tetanus toxoid booster vaccine injection Recovery can take months and significant weight loss if always seen Management of tetanus prone injuries: Wounds sustained >6 hours before surgical treatment or any wound with exposure to soil/manure, foreign bodies, compound fracture or clinical evidence of sepsis. Thoroughly clean the wound Give human tetanus Ig ASAP if high risk Where fully vaccinated or up to date with schedule, no further doses are recommended If unknown status, immunocompromised or not up to date, reinforcing dose of Td/IPV should be given when treated and further doses given to complete recommended five dose schedule
49
Diphtheria
Background: Acute URTI that can sometimes infect the ski Cases are now rare due to herd immunity Mainly occurs in epidemics Pathology: Pathogenic only in humans, spread via respiratory droplets Incubation usually 2-5 days but can be up to 10 days Pharyngeal or cutaneous infection is caused by toxigenic strains Exotoxin produced affects a number of tissues including the heart, peripheral nerves and kidneys Aetiology: Corynebacterium diphtheria AB toxin (gram positive aerobic bacillus) Risk factors: Poor hygiene and living conditions Lack of immunisation Adults at risk of losing immunisation without boosters
50
Diphtheria presentation, investigation, management and prevention
``` Presentation: Early symptoms - common cold/URTI Rhinnorhoea which begins very watery then becomes purulent and blood stained Fibrinous pseudomembrane usually on the respiratory mucosa which may cause respiratory obstruction Dysphagia Paralysis Heart failure Asymptomatic ``` Investigation/diagnosis: Throat/sputum swab culture is diagnostic Management: Antitoxin prevents entry to cells Antibiotics - erythromycin, azithromycin, clarithromycin or penicillin Can give antibiotic prophylaxis to those who have had close contact Prevention: DTP vaccine - inactivated toxin
51
erythema infectiosum
Background: AKA slapped cheek Very common childhood infection occurring between the ages of 3-15 years Pathology: Spread via droplet transmission, blood/bone marrow transplant or vertical transmission (mum-baby) Typically takes 4-20 days incubation Lifelong immunity after being exposed to the virus Aetiology: Parvovirus B19 Risk factors: Most common in children
52
erythema infectiosum presentation and differentials
Presentation: Asymptomatic in 25% of infections Non-specific coryza symptoms Headaches Rhinitis Sore throat Low grade fever Typically 7 days after being symptoms free develop facial rash - slapped cheek red face rash Can spread to the rest of the body 2-3 days after appearing on the face Arthropathy (more common in adults than children) Differentials: Rubella: very similar rash over the whole body Measles: check for Koplik spots Scarlet fever: look for strawberry tongue Roseola: similar rash Drug eruption: new medications?
53
erythema infectiosum investigation and management and pregnancy
Investigation/diagnosis: Clinical diagnosis If uncertain/pregnant - PCR test for parvovirus B19 Bloods - specific to IgM and IgG checking for immunity and current infection Management: Self limiting viral infection Regular OTC analgesia, symptomatic management Avoid any immunocompromised or pregnant people Do NOT need to avoid school, but do need to make anyone pregnant at the school aware Pregnancy: 30% chance of passing infection onto baby Baby fatality 10% if infected, higher in the first trimester Can cause congenital abnormality If been in contact with someone infected, must be investigated (ask if any previous history of parvovirus in childhood, bloods and PCR) If they have active infection: refer to foetal medicine unit to check for foetal infection
54
rabies
Background: Occurs in >150 countries Viral infection affecting the nervous system, causing encephalitis or meningoencephalitis Not all individuals exposed to rabies virus develop the disease, however once symptoms occur, rabies is almost always fatal Pathology: Carried by warm blooded animals (foxes, bats, dogs, raccoons) Transmitted by saliva into bite wounds most commonly. The virus is weak and inactivated by drying, UV rays and detergents 4-13 weeks incubation Virus infects neural tissue and evades the immune response, amplification occurs and the virus spreads along the nervous system, entering spinal ganglions Once in ganglions the onset of pain or paraesthesia begins and spreads rapidly with marked encephalitis Finally the virus spreads peripherally including salivary glands Aetiology: Rhabdovirus (bullet shaped) single stranded RNA virus
55
rabies risk factors and presentation
Risk factors: Children are more at risk as are more likely to approach animals without caution Travel to areas with high prevalence ``` Presentation: Insidious onset Pain and paraesthesia around wound Malaise, fever, headaches, pruritus that spreads around the body Muscle spasms Sore throat Hydrophobia due to difficulty swallowing Hallucinations Behavioural disturbances Ascending flaccid paralysis with sensory disturbances and coma Respiratory paralysis resulting in death ```
56
rabies investigation, managent and prevention
Investigation/diagnosis: PCR for viral antigens Nuchal skin biopsy (hairline from base of neck sample) Post-mortem tissue biopsy Management: Clean wound Immunisation with rabies Ig (RIG) Prevention: Vaccine available - attenuated virus
57
cytomegalovirus
Background: A member of the human herpes virus family Infection is worldwide and usually asymptomatic, but can cause severe illness in congenital infection or immunocompromised hosts Most common presentation is gastroenteritis Most serious complication is pneumonia Pathology: Uses human hosts, transmitted by saliva and sexual contact UTI moves to kidneys, salivary glands, cervix and testes May cause a mononucleosis infection in healthy individuals but can cause severe illness in congenital infection or immunocompromised patients Remains in a persistent state within the host after the initial infection, controlled by the immune system. Intermittent viral shedding can take place in immunocompetent people Aetiology: Human herpes virus Risk factors: Congenital infection/pregnancy Immunocompromised patients
58
cytomegalovirus presentation and investigations
Presentation: Often asymptomatic Glandular fever like symptoms Foetal malformations in congenital CMV disease Hepatitis Pneumonia In immunocompromised patients - pneumonitis, CNS, colitis, hepatitis ``` Investigation/diagnosis: Measure CMV load Urinalysis - CMV load Bloods - CMV load, FBC, serum creatinine and LFTs CXR - pneumonia CT - lung infiltrates Biopsy ```
59
cytomegalovirus management and prevention
Management: Antivirals - IV ganciclovir, foscarnet to reduce viral load for a minimum of 14 days Additional 1-3 months of appropriate prophylaxis should be considered to minimise risk of recurrent infection (determine duration using PCR monitoring of viral load) Organ transplants Prevention: No vaccine All organ donors and recipients are screening for CMV status before or after transplantation Antiviral prophylaxis can be given for 3-6 months in some circumstances
60
Epstein-Barr virus
Background: EBV AKA human herpesvirus 4 is widespread and one of the most common human viruses worldwide Member of the herpes virus family Most people are infected with EBV at some point in their lives Most common cause of infectious mononucleosis Pathology: Spread commonly through bodily fluids (saliva) Infects B lymphocytes and epithelial cells Can cause infectious mononucleosis in roughly 50% of primary infections Also associated with tumours such as Burkitt’s lymphoma, Hodgkin’s disease, B-lymphoproliferative disease Nasopharyngeal carcinomas and oral hairy leukoplakia can also be associated. In congenital infection can cause X linked lymphoproliferative syndrome Can also play a role in autoimmune diseases like SLE, RA and MS but pathology is unknown. Primary infection is often mild or asymptomatic or causes mumps. After primary infection the virus becomes latent however in immunocompromised individuals may reactivate Aetiology: HHV-4/EBV viral infection Risk factors: Immunocompromised - risk of reactivation of latent infection
61
Epstein-Barr virus presentation, Investigation and management and prevention
``` Presentation: Fatigue Fever Inflamed throat Lymphadenopathy Hepatosplenomegaly Rash ``` Investigation/diagnosis: Clinical diagnosis (difficult due to vague presentation) PCR and viral antibodies (MONOSPOT test - looks for heterophile antibodies) Bloods - FBC (WCC and monospot test), LFTs (raised ALT) Management: Usually self limiting within 2-4 weeks, fatigue can last for longer Do not need to isolate from school (with infectious mononucleosis) Arrange hospitalisation for signs of dehydration, stridor or complication such as ruptured spleen Avoid exercise for at least one month after recovery due to risk of splenic rupture Fluid intake Rest Regular analgesia as needed Treat immunocompromised states Prevention: Avoiding kissing, sharing personal items, drinks with those showing signs of infection
62
Herpes simplex virus
Background: Most individuals are infected with HSV-1 by 1-2 years of age (1 = above waist) HSV-2 tends to be with onset of sexual activity (2 = below waist) Usually is asymptomatic Most contagious when virus filled lesions are present but can also be shed when asymptomatic In individuals with atopic dermatitis can present with very severe herpes virus blistering in these areas due to weakness of skin barriers (eczema herpeticum) and also can have very similar severe viral blisters in those with burn injuries. Complications include meningitis or encephalitis if viral infection reaches the brain (typically in the TEMPORAL LOBE) Pathology: Primary infection occurs through a break in the mucous membranes of the mouth, throat, eyes, genitals or skin abrasions. Can also be spread via vertical transmission Virus internalised in cells then begins lytic cycle of proliferation Cells burst and virus spreads to other cells Can also infect sensory neurons and lays latent there in the trigeminal ganglia (oral herpes) or sacral ganglia (genital warts) and lies dormant until an immunocompromised state allows for the virus to travel back down the neurons and infect the cells Triggers include stress, skin damage and viral illness. Aetiology: HSV-1 and HSV-2 Enveloped, double stranded DNA viruses
63
herpes simplex virus risk factors and presentation
Risk factors: Triggers include stress, skin damage and viral illness. ``` Presentation: Oral: Often asymptomatic Tingling or burning sensation Blisters appearing on the sides of the mouth, heal within a few weeks and often painful Lesions on palate, lip, gums, tongue LAP Pharyngitis ``` Genital herpes: Ulcers and pustules of labia, mons pubis, vaginal mucosa, cervix, shaft of penis Resolve within a week Herpetic whitlow: Finger has been in contact with lesion directly (autoinoculation) Blisters on fingers Easy spread to other areas of the body such as the trunk, extremities and head Eczema herpeticum: In individuals with atopic dermatitis can present with very severe herpes virus blistering in these areas due to weakness of skin barriers ``` Eyes: Keratoconjunctivitis Blurry vision Pain Redness Tearing ``` Neonatal infection: Skin, eye or mucous membrane infection CNS infection (lethargy, seizures, irritable, LP changes suggestive of HSV encephalitis) Disseminated infection (sepsis and organ failure) Immunocompromised: More frequent reactivation More severe blistering More symptoms such as lesions of the oesophagus or lungs
64
herpes simplex virus investigation and management
``` Investigation/diagnosis: Clinical diagnosis PCR viral DNA Viral cultures Viral antibodies LP for meningitis or encephalitis symptoms - shows increased RBCs, WBCs and protein CT, MRI, EEG ``` ``` Management: Usually self limiting Topical or systemic antivirals within prodromal phase to help speed up recovery Topical analgesic OTC for oral lesions Acyclovir, famciclovir or valacyclovir ```
65
influenza
Background: Types A and B are most common Type A has different subtypes (H and N) each with different strains e.g. H1N1 is swine flu and H5N1 is avian flu Outbreaks typically occur in the winter Pathology: An RNA virus with three types (A, B and C) Complications - otitis media, sinusitis, bronchitis, viral pneumonia, secondary bacterial pneumonia, worsening of chronic conditions, febrile convulsions (young children) and encephalitis. Aetiology: Influenza RNA virus Risk factors: Immunocompromised or long standing comorbidities
66
influenza presentation, investigation, management and prevention
``` Presentation: Fever Coryzal symptoms Lethargy and fatigue Muscle and joint aches Headache Dry cough Sore throat Anorexia (loss of appetite) ``` Investigation/diagnosis: Usually clinical diagnosis Viral nasal or throat swabs (PCR) for diagnosis and notification to public health to monitor number of cases Management: Public health monitor the number of flu cases and provide guidance on when there is enough cases to justify treatment for suspected flu Healthy individuals do not require antivirals - self care measures, adequate fluid intake and rest advice, paracetamol PRN for fever and aches Antivirals (oral oseltamivir 75 mg BD for 5 days OR inhaled zanamivir 10 mg BD for 5 days) should be given within 48 hours of symptom onset to be effective in those at high risk of complications Post exposure prophylaxis can be given to high risk patients within 48 hours of close contact to someone with influenza (same drugs, same dose but 10 day course instead) Prevention: Good hygiene Vaccination yearly changed to target multiple strains of influenza likely to cause flu that year. Given free to those aged >65, young children, pregnant women, those with chronic health conditions like asthma, COPD, heart failure and diabetes and healthcare workers and carers
67
mumps and presentation
Background: Vaccine offers around 80% protection for mumps so taking vaccination history is very important Pathology: Viral infection spread by respiratory droplets Incubation period of 14-25 days Usually a self limiting illness lasting around 1 week ``` Aetiology: Viral infection (mumps) ``` ``` Presentation: Parotid swelling Fever Muscle aching Lethargy Reduced appetite Headaches Dry mouth Complications - abdominal pain (pancreatitis), orchitis (testicular pain), meningitis or encephalitis (confusion, neck stiffness and headaches) ```
68
mumps investigation, management, prevention
Investigation/diagnosis: Clinical diagnosis Viral PCR of saliva and antibody testing Management: Notify public health (notifiable disease) Fluids Rest Analgesia as needed Management of complications (pancreatitis, orchitis, meningitis or encephalitis or sensorineural hearing loss) Prevention: MMR vaccine programme in children
69
roseola and presentation
Background: Sixth disease Complications include febrile convulsions and rarely encephalitis Pathology: Viral human herpes - 6 infection Self limiting condition Aetiology: HHV-6 and possibly HHV-7 Risk factors: Ages 6 months - 1 year Presentation: Abrupt high fever lasting 3-5 days Followed by an erythematous maculopapular rash that appears as the temperature subsides Rash initially on the trunk, spreads centrifugally to the face and limbs Nonspecific viral illness symptoms or asymptomatic
70
roseola management and investigation
Investigation/diagnosis: Clinical diagnosis Viral PCR and antibodies Management: Good fluid intake Calpol for fever and irritability Bring to hospital if any signs of confusion, excessive drowsiness, not drinking or severely decreased urine output or signs of encephalitis or not improving after 7 days
71
rubella
Background: AKA 3rd disease or german measles Generally mild disease in childhood Mainly common in spring and summer months Can cause severe foetal damage in vitro in pregnant women: causes foetal cell cytolysis through vasculitis and immune-mediated inflammation Is part of MMR vaccine for this purpose Pathology: Incubation for 14-21 days Transmitted via droplet infection Aetiology: RNA viral infection
72
rubella presentation
Prodromal symptoms of malaise, coryza, cough, LAP Pink macular and papular rash starting on the forehead and spreading on the face, trunk and extremities on the first day of infection (after 1-5 days of illness) Fades on the second day on the face and rest of the body on the third day Petechiae on soft palate before the rash Low fever Congenital rubella syndrome: Classic triad of cataract, cardiac deformities and deafness (microcephaly) Maternal viremia with rubella infections during pregnancy may result in infection of the placenta and foetus causing these developmental defects Growth cells in foetus are reduced and some reduced after birth Prevented with effective immunisation Few cases people develop ear encephalitis: treated with rest, tylenol or non-aspirin pain relief for fever Congenital rubella has poor prognosis and many children die from heart problems; those who survive need lifelong treatment for deafness, learning disabilities and other congenital problems etc.
73
rubella investigation, management and prevention
Investigation/diagnosis: Clinical history and exam (difficult as rash is fleeting and mimics any viral rash) Rubella testing kit confirms diagnosis Management: self limiting disease Notify local health teams Keep children from school for at least 4 days after rash has gone to limit spread to others Ask about any contact with pregnant women ``` Complications: Thrombocytopenia Encephalitis Purpura Arthritis ``` Prevention: MMR vaccine in childhood
74
measles (rubeola)
Background: AKA 1st disease or rubeola Pathology: Enters cells and alters RNA transcription Transmitted through airborne droplets: extremely contagious (if 1 person has it; 90% non-immune people nearby will get it) Infects respiratory epithelium and spreads to skin and other organs Incubation roughy 10-14 days Once infected/immunised have life long immunity Aetiology: RNA virus
75
measles presentation and investigation
4 Cs - cough, coryza, conjunctivitis and very cranky 2 distinct phases: Prodrome (2-4 days) or exanthem (7-10 days) Prodrome phase: fever, rhinorrhoea, cough, conjunctivitis, Koplik's spots Exanthem: maculopapular rash starting behind the ears then spreading to forehead, neck, face, trunk, upper limbs, buttocks and lower limbs. Fever peaks with rash then decreases over 4-5 days Cough may remain post infection in recovery period In immunocompromised pts. They may not present with enanthem (Koplik spots) or exanthem (rash) but show higher rates of pneumonia and encephalitis meaning they have higher mortality rates Investigation/diagnosis: Clinical exam and history IgM measles specific swab or serum sample to confirm diagnosis
76
measles management and prevention and complications
Management: Supportive treatment; disease is usually self limiting Human immunoglobulin may be given within 5 days following exposure to unimmunised children (<3years), immunocompromised and pregnant women Vaccinate other household members PRN Vitamin A for young children and severely malnourished pts may decrease complication risk and boost antibody response Notifiable disease: inform local health protection teams of suspected cases Prevention: Vaccine given as MMR Given at 12-15 months then again at 4-6 years 95% efficacy rate Mothers give transplacental antibodies lasting until 9 months old roughly Complications Associated with miscarriage and premature delivery in pregnant women Post measles encephalomyelitis within 2 weeks onset of rash in immunocompromised children (poor prognosis - autoimmune reaction) Suppresses immunity for up to 6 wks: Bacterial superinfections: Otitis media or bacterial pneumonia (mostly in young infants) <2 years: subacute sclerosing panencephalitis (can occur up to 10 years later): caused by persistent measles infection due to abnormal immune response or mutated viral strain leading to inflammation of the entire brain. Symptoms initially subtle like mood changes but lead to seizures, coma, death.
77
varicella zoster viral infection
Background: Common illness manifesting as general vesicular rash Extremely contagious spread by respiratory droplets (in unvaccinated population 90% would become infected) Predominant age of infection is 5-10 years Infectious period begins 2 days prior to symptom onset and lasts until all lesions have crusted Incubation period around 9-21 days Pathology: Varicella zoster virus (VZV) infects respiratory cells and liver and spleen in the primary viremia stage; then to the T cells in secondary viremia at around 2 weeks post-infection. T cells release pathogens to skin causing skin lesions as keratinocytes etc are infected. Aetiology: VZV infection Risk factors: Pregnancy Immunocompromised
78
VZV presentation, investigation and complications
Presentation: Brief prodromal period with fever, chills, headache and malaise Lesions start to appear over head and trunk, spreading to peripheries Often very itchy New lesions generally stop appearing after day 4 Investigation/diagnosis: Clinical diagnosis Lesion scraping to confirm PRN ``` Complications: Secondary bacterial infections leading to necrotising fasciitis or toxic shock syndrome Viral pneumonia Encephalitis Aseptic meningitis Vasculitis Osteomyelitis Otitis media Sepsis ```
79
VZV management and prevention
Management: Self- limiting disease supportive care given Paracetamol, antihistamines Avoid contact with pregnant women, neonates, immunocompromised If pt is immunocompromised then specialist advice needed as may need IV acyclovir (antiviral) Management in pregnancy: Check maternal bloods for VZV antibodies If <20 weeks gestation and not immune, give VZV Igs ASAP preferably within 10 days post exposure If >20 weeks and not immune, give antivirals (aciclovir or valaciclovir) given on days 7-14 after exposure prevention: vaccine for unexposed individuals working in healthcare